Epidemic Keratoconjunctivitis—Detroit Experience

Publisher Website
Google Scholar
Abstract
The use of a 30 mg. % soln. of tyrothricin in the treatment of cases of epidemic kerato-conjunctivitis was suggested. The writers and their associates began to use tyrothricin on cases of epidemic kerato-conjunctivitis late in the period of the epidemic and the clinical impression after the use of the product in a small series of cases was that the duration of the disease appeared to be somewhat shortened. Approx. % of the patients claimed that they experienced some symptomatic relief. The most significant impression was the marked reduction in the incidence of complications. 219 cases are analyzed, of which 120 were treated by other methods and 99 were treated with tyrothricin. The results do not reveal an appreciable difference in the duration of those cases treated with tyrothricin as compared to those treated by some other method.

This publication has 0 references indexed in Scilit: